Pubblicazioni

Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience

2021 - JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Sala, E.; Carosi, G.; Del Sindaco, G.; Mungari, R.; Cremaschi, A.; Serban, A. L.; Ronchi, C. L.; Ferrante, E.; Arosio, M.; Mantovani, G.

The safety of available treatments options for neuroendocrine tumors

2017 - EXPERT OPINION ON DRUG SAFETY

Faggiano, A.; Lo Calzo, F.; Pizza, G.; Modica, R.; Colao, A.

Expression of peroxisome proliferator-activated receptor alpha (PPARÃÂ±) in somatotropinomas: relationship with aryl hydrocarbon receptor interacting protein (AIP) and in vitro effects of fenofibrate in GH3cells

2016 - MOLECULAR AND CELLULAR ENDOCRINOLOGY

Rotondi, Sandra; Modarelli, Alessio; Oliva, Maria-Antonietta; Rostomyan, Liliya; Sanita, Patrizia; Ventura, Luca; Daly, Adrian F.; Esposito, Vincenzo; Angelucci, Adriano; Arcella, Antonietta; Giangaspero, Felice; Beckers, Albert; Jaffrain-Rea, Marie-Lise

Pubblicazioni

Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience

The safety of available treatments options for neuroendocrine tumors

Expression of peroxisome proliferator-activated receptor alpha (PPARÃÂ±) in somatotropinomas: relationship with aryl hydrocarbon receptor interacting protein (AIP) and in vitro effects of fenofibrate in GH3cells

Expression of peroxisome proliferator-activated receptor alpha (PPARÃÂ±) in somatotropinomas: relationship with aryl hydrocarbon receptor interacting protein (AIP) and in vitro effects of fenofibrate in GH3cells